Literature DB >> 17579856

Predicting response to chemoradiotherapy in rectal and oesophageal cancer with 18F-FDG: prognostic value and possible role in patient management.

Elif Hindié, Christophe Hennequin, Jean-luc Moretti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17579856     DOI： 10.1007/s00259-007-0483-5

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  39 in total

Review 1.  Monitoring cancer treatment with PET/CT: does it make a difference?

Authors:  Wolfgang A Weber; Robert Figlin
Journal:  J Nucl Med       Date:  2007-01       Impact factor: 10.057

2.  Local excision of T2 and T3 rectal cancers after downstaging chemoradiation.

Authors:  C J Kim; T J Yeatman; D Coppola; A Trotti; B Williams; J S Barthel; W Dinwoodie; R C Karl; J Marcet
Journal:  Ann Surg       Date:  2001-09       Impact factor: 12.969

3.  Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification.

Authors:  Paul M Schneider; Stephan E Baldus; Ralf Metzger; Martin Kocher; Rudolf Bongartz; Elfriede Bollschweiler; Hartmut Schaefer; Juergen Thiele; Hans P Dienes; Rolf P Mueller; Arnulf H Hoelscher
Journal:  Ann Surg       Date:  2005-11       Impact factor: 12.969

4.  Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.

Authors:  Claus Rödel; Peter Martus; Thomas Papadoupolos; Laszlo Füzesi; Martin Klimpfinger; Rainer Fietkau; Torsten Liersch; Werner Hohenberger; Rudolf Raab; Rolf Sauer; Christian Wittekind
Journal:  J Clin Oncol       Date:  2005-10-24       Impact factor: 44.544

5.  Relationship between pathologic T-stage and nodal metastasis after preoperative chemoradiotherapy for locally advanced rectal cancer.

Authors:  Salvatore Pucciarelli; Carlo Capirci; Urso Emanuele; Paola Toppan; Maria Luisa Friso; Gian Maria Pennelli; Giovanni Crepaldi; Lara Pasetto; Donato Nitti; Mario Lise
Journal:  Ann Surg Oncol       Date:  2005-02-04       Impact factor: 5.344

6.  Impact of CT and 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma.

Authors:  Laurence Moureau-Zabotto; Emmanuel Touboul; Delphine Lerouge; Elisabeth Deniaud-Alexandre; Dany Grahek; Jean-Noël Foulquier; Yolande Petegnief; Benoît Grès; Hanna El Balaa; Kaldoun Kerrou; Françoise Montravers; Katia Keraudy; Emmanuel Tiret; Jean-Pierre Gendre; Jean-Didier Grange; Sidney Houry; Jean-Noël Talbot
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-10-01       Impact factor: 7.038

7.  The utility of positron emission tomography in staging of potentially operable carcinoma of the thoracic esophagus: results of the American College of Surgeons Oncology Group Z0060 trial.

Authors:  Bryan F Meyers; Robert J Downey; Paul A Decker; Robert J Keenan; Barry A Siegel; Robert J Cerfolio; Rodney J Landreneau; Carolyn E Reed; Dennis M Balfe; Farrokh Dehdashti; Karla V Ballman; Valerie W Rusch; Joe B Putnam
Journal:  J Thorac Cardiovasc Surg       Date:  2007-03       Impact factor: 5.209

8.  Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203.

Authors:  Jean-Pierre Gérard; Thierry Conroy; Franck Bonnetain; Olivier Bouché; Olivier Chapet; Marie-Thérèse Closon-Dejardin; Michel Untereiner; Bernard Leduc; Eric Francois; Jean Maurel; Jean-François Seitz; Bruno Buecher; Rémy Mackiewicz; Michel Ducreux; Laurent Bedenne
Journal:  J Clin Oncol       Date:  2006-10-01       Impact factor: 44.544

Review 9.  Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis.

Authors:  F Fiorica; D Di Bona; F Schepis; A Licata; L Shahied; A Venturi; A M Falchi; A Craxì; C Cammà
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

10.  Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy.

Authors:  Carlo Capirci; Lucia Rampin; Paola A Erba; Fabrizio Galeotti; Giorgio Crepaldi; Elena Banti; Marcello Gava; Stefano Fanti; Giuliano Mariani; Pier Carlo Muzzio; Domenico Rubello
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-05-15       Impact factor: 9.236
View more
  3 in total

1.  The emerging role of FDG PET/CT in rectal cancer management: is it time to use the technique for early prognostication?

Authors:  Luca Tagliabue
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-05       Impact factor: 9.236

2.  Evaluation of early response to concomitant chemoradiotherapy by interim 18F-FDG PET/CT imaging in patients with locally advanced oesophageal carcinomas.

Authors:  Xavier Cuenca; Christophe Hennequin; Elif Hindié; Sofia Rivera; Laetitia Vercellino; Valérie Baruch-Hennequin; Jean-Marc Gornet; Pierre Cattan; Mircea Chirica; Laurent Quéro
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-02-01       Impact factor: 9.236

3.  Carcinoembryonic Antigen Improves the Performance of Magnetic Resonance Imaging in the Prediction of Pathologic Response after Neoadjuvant Chemoradiation for Patients with Rectal Cancer.

Authors:  Gyu Sang Yoo; Hee Chul Park; Jeong Il Yu; Doo Ho Choi; Won Kyung Cho; Young Suk Park; Joon Oh Park; Ho Yeong Lim; Won Ki Kang; Woo Yong Lee; Hee Cheol Kim; Seong Hyeon Yun; Yong Beom Cho; Yoon Ah Park; Kyoung Doo Song; Seok-Hyung Kim; Sang Yun Ha
Journal:  Cancer Res Treat       Date:  2019-09-25       Impact factor: 4.679
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.